FDA Rare Disease Hub “Policy & Portfolio Council” Is First Step In CBER/CDER Coordination; Hub Agenda For 2025 Includes Three Scientific Workshops

You must be a logged-in member of this site to view this article.

To request more information about a company license to the Prevision Policy continuous information service or to get further details about the services we offer, please click here.

Alternatively, if your organization already has a license and you do not yet have an account, please click here to request access.